This antibody is a strong inhibitor not only of ligand-dependent invasive growth, sustained by both paracrine and autocrine HGF, but notably, also of ligand-independent growth of Met-addicted cells.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-H24 | Anti-Human MET Recombinant Antibody (Emibetuzumab) | FuncS, IF, Neut, ELISA, FC, IP, WB | IgG4 - kappa |
TAB-190-F(E) | Anti-Human Met(Onartuzumab) | IP, IF, FuncS, FC, Neut, ELISA, ICC | Fab / Fc - G1 - kappa |
TAB-521CL | Anti-Human MET Recombinant Antibody (ABT-700) | WB, FuncS | Antibody |
TAB-0332CL | Human Anti-MET Recombinant Antibody (TAB-0332CL) | ELISA | Humanized Antibody |
TAB-026MZ | Anti-Human MET Recombinant Antibody (73R009) | WB | Humanized antibody |
There are currently no Customer reviews or questions for TAB-002MZ-F(E). Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.